Facial anomalies including underdeveloped cheekbones and jawbones, along with hair loss, define MFDA; ETAR gain-of-function mutations disrupt signaling pathways.
An Iranian study of 45 participants found six pathogenic variants in MODY, a monogenic, autosomal dominant diabetes that is often mistaken for type 1 or type 2.
Because its symptoms overlap type 1 and type 2 diabetes, MODY type 14 is often missed; APPL1 testing confirms the autosomal dominant cause and shapes treatment.
Research in Pakistani patients tied FokI and BsmI polymorphisms in the Vitamin D receptor gene to this recessive form of microcephaly; carrier testing is also covered.
Both head size and brain volume are reduced in this recessive form of microcephaly. There is no cure; physical, occupational and speech therapy can help.
TUBGCP4 keeps cell division stable; when it fails, MCC3 brings small head size, developmental delay and progressive vision loss from retinal atrophy.
Whole exome sequencing can reveal the variants behind this syndrome's microcephaly, corpus callosum hypoplasia, intellectual disability and facial features.
Small head size, intellectual disability, sensorineural hearing loss, epilepsy and abnormal muscle tone define this syndrome; DNA analysis helps pin down its cause.